Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16042660 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial
Condition: Non-erosive Reflux Disease
Interventions: Drug: Fluoxetine;   Drug: Omeprazole;   Drug: placebo

Indicates status has not been verified in more than two years